Current Opinion in Urology

Article	Citations
Editorial introductions	69
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies	47
Research frontiers in urology	45
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis	43
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects	25
Exploring the impact of artificial intelligence–enabled decision aids in improving patient inclusivity, empowerment, and education in urology: a systematic review by EAU endourology	23
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments	21
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma	21
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update	19
The role of innovations in advancing urologic oncologic patient care	18
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker	18
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder	17
Editorial introductions	17
Editorial introductions	16
RNA-based urinary assays for non-muscle invasive bladder cancer	16
Testicular cancer with small metastatic burden: optimal approach in 2024	15
Editorial introductions	15
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer	15
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations	14
Sustainable practices in hospital and operating theaters	13
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma	13
Tissue-based gene expression testing in localized prostate cancer	12
Optimizing clinical risk stratification of localized prostate cancer	11
Perioperative systemic therapy, current paradigm and ongoing clinical trials in upper tract urothelial cancer	11
Risk of dementia associated with the use of anticholinergic medications: a review of recent literature	11

Oncolytic virus therapy for nonmuscle-invasive bladder cancer: current status and future directions	11
Does radical cystectomy still have a role in BCG-unresponsive nonmuscle invasive bladder cancer?	11
Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging	11
Should endoscopic laser excision be offered as the first-line management for patients with eroded mesh? Outcomes of a systematic review of literature	11
Sexually transmitted infections and the vaginal microbiome after vaginoplasty	10
Is there a role for metastasis-directed therapy in bladder cancer?	9
Guiding treatment decisions in renal cell carcinoma: the role of biomarkers and clinical factors	9
Perioperative platform for muscle-invasive bladder cancer trials: designs and endpoints	9
Update on classification of oncocytic neoplasms of the kidney	9
All about pulsed thulium:YAG laser: a systematic review from YAU Endourology and EAU Endourology	9
Lutetium-177-prostate-specific membrane antigen therapy for prostate cancer: current status and future prospects	9
Histologic subtypes of urothelial carcinoma: an update	8
Management of vaginoplasty canal complications	8
Brief update of the new WHO classification for urothelial carcinoma	8
Metabolic syndrome, obesity and cancer risk	8
Preoperative geriatric assessment of urological patients: a narrative review	8
Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities	8
Retrograde intra renal surgery and safety: pressure and temperature. A systematic review	7
Alternatives to whole gland treatment for localized prostate cancer: a review of novel focal therapies	7
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors	7
Patient-reported outcomes in genital gender-affirming surgery	7
The role of surgery for locally advanced urothelial cancers	7
Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis	7
Preoperative patient optimization for endourological procedures: the current best clinical practice	7
Extent of lymph node dissection and impact on survival in radical cystectomy for advanced bladder cancer	7
The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer	7
Toxicities of taxane-based chemotherapy in prostate cancer	7
Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance	7
Comparison of surgical effectiveness: kidney sparing surgery for upper tract urothelial carcinoma	7
Decoding germ cell tumours for clinicians	7
MR-guided radiotherapy for prostate cancer: an inevitable transition?	6
Liquid biomarkers in prostate cancer: recent advancements and future directions	6
Bladder-sparing strategies in patients with clinically localized muscle-invasive bladder cancer	6
Toxicities of radioligand and radioisotope therapy in prostate cancer: a systematic review and meta-analysis	6
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer	6
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes	6
Medical therapy for male infertility	6
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma	6
Advanced sperm tests and impact on clinical male factor management	6
Next-gen minimally invasive surgical therapies for benign prostatic hyperplasia: innovations, selection, and best practices- a review from European Association of Urology endourology	6
Percutaneous management of caliceal diverticula: a narrative review	6
Editorial introductions	6
Lasers for benign prostatic hyperplasia (hybrid, blue diode, TFL, Moses). Which one to choose?	6
AI-powered radiomics: revolutionizing detection of urologic malignancies	6
Implications and effects of COVID-19 on diagnosis and management of prostate cancer	6
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature	6
Surgical management of testicular cancer with limited retroperitoneal disease	5
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis	5
The environmental impacts of anesthesia	5
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses	5

Use of genomic markers to improve epidemiologic and clinical research in urology	5
Genetics of testicular cancer: a review	5
Metabolic evaluation: is there really a future?	5
Cost-effectiveness of serum, urine, and tissue-based prostate cancer biomarkers	5
Ultra-hypofractionation for the treatment of macroscopic prostate bed recurrence: a focus on stereotactic radiotherapy and brachytherapy	5
Inflammation and kidney stones: cause and effect?	5
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era	5
Editorial introductions	5
Overlooked and underserved: how healthcare fails men in the pursuit of equity	5
The carbon footprint of modern imaging	5
Medical management of male infertility: now and future	4
How to present quality of life outcomes after focal therapy: using validated instruments and novel statistical methods	4
New technologies for nephron-sparing surgery in upper urinary tract cancers	4
The use of MRI in urothelial carcinoma	4
Organ storage in renal transplantation	4
En-bloc resection of non-muscle invasive bladder cancer: does it really make a difference?	4
Role of cytoreductive surgery in the era of immunotherapy	4
Transperineal vs. transrectal biopsy to reduce postinterventional sepsis	4
Bladder diverticula management – conservative and surgical outcomes: a narrative review from EAU endourology	4
Nectin-4 in bladder cancer: biology and predictive biomarker potential	4
Small tools, big impact and redefining endourology: the paradigm shift of ureteroscopy for large stones and percutaneous nephrolithotomy for small stones – a literature review	4
Advances in ureteral stent technology	4
What’s in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters	4
Novel intravesical delivery systems for nonmuscle invasive bladder cancer	4
Editorial: Future of kidney stone management	4
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population	4
Editorial introductions	4
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers	4
Urachal cancer: a clinical, diagnostic, and therapeutic update	4
Editorial introductions	4
Editorial introductions	4
Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherap	4
The urothelial barrier in interstitial cystitis/bladder pain syndrome: its form and function, an overview of preclinical models	4
Integration of novel artificial intelligence tools in pediatric urologic practice	4
The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis	4
Editorial introductions	4
Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review	4
Preclinical models for bladder cancer therapy research	4
Pelvic pain syndromes	4
Current position of neuromodulation for bladder pain syndrome/interstitial cystitis	4
Leveraging behavioral modification technology for the prevention of kidney stones	4
Artificial intelligence in endourology: emerging technology for individualized care	4
Endo-technology and its future: where are we heading?	4
Optimal systemic therapy in men with low-volume prostate cancer	3
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology	3
Drug instillation in the management of urinary tract urothelial carcinoma	3
Radical cystectomy and women's sexual health – can we do better?	3
Angiomyolipoma/PEComa: the past, the present…and back to the future	3
The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement	3
Recent advancements in personalized management of prostate cancer biochemical recurrence after radical prostatectomy	3
The future of laser technology in kidney stones	3
Pembrolizumab in mCRPC – Combination therapies as breakthrough to success?	3
Diagnostic evaluation for adrenal tumors – What does the urologist need to know about endocrine metabolic work up?	3
Simulation training in urology	3
Retrograde intrarenal surgery: laser showdown (Ho:YAG vs thulium fiber laser)	3
Metastasis-directed treatment in kidney cancer	3
Implications of DNA damage repair alterations for the management of prostate cancer	3
The spread of retzius-sparing robotic prostatectomy: an update after 10 years	3
Review of second-generation androgen receptor inhibitor therapies and their role in prostate cancer management	3
Chronic pelvic pain; more than just the bladder	3
Reducing financial toxicity in bladder cancer care	3
Impact of lifestyle and environmental factors on fertility	3
Urinary continence in high-risk prostate cancer after robot-assisted radical prostatectomy	3
Editorial introductions	3
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions	3
En bloc resection of large bladder tumor: is it feasible and reasonable?	3
Polygenic risk score in prostate cancer	3
Artificial intelligence in muscle-invasive bladder cancer: opportunities, challenges, and clinical impact	3
Where are we in 2024 in the development of materials for surgical treatment of pelvic organ prolapse and stress urinary incontinence?	3
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?	3
Clinical and pathologic characteristics to select patients for focal therapy or partial gland ablation of nonmetastatic prostate cancer	3
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?	3
The role of cytoreductive nephrectomy in the immuno-oncological therapy era	3
Radioguided surgery for lymph node metastases in prostate cancer	3
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine	3
Measuring quality of life in patients with kidney stone disease: is it the future in endourology?	2
ChatGPT in urology practice: revolutionizing efficiency and patient care with generative artificial intelligence	2
Evaluation and management of male genital tract infections in the setting of male infertility: an updated review	2
Future directions in transfeminine genital gender-affirming surgery: tissue substitutes and transplant	2
A narrative review on the performance and outcomes of penile and scrotal surgery in the ambulatory setting	2

The quality of life value in uro-oncological patients	2
Novel germline mutations for active surveillance and imaging strategies in prostate cancer	2
The role of suction devices in enhancing outcomes of retrograde intrarenal surgery: a narrative review by the YAU urolithiasis and section of EAU endourology	2
Editorial introduction	2
Robotic-assisted retroperitoneal lymph node dissection for testicular cancer	2
Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence	2
Micropapillary bladder cancer: an evolving biology	2
VISION, TheraP, LuTectomy and beyond – is there a role for lutetium therapy in biochemical recurrence?	2
The role of nuclear medicine tracers for prostate cancer surgery: from preoperative to intraoperative setting	2
Artificial urinary sphincter: recent developments and the way forward	2
Electromagnetic-guided puncture: a tool or a tale?	2
Assessing the ripple effects of natural disasters on healthcare systems: a narrative review	2
Bacillus Calmette-Guérin unresponsive NMIBC: novel therapies and concepts	2
Advancing men's health: insights and innovations	2
Salvage radical prostatectomy	2
Tumour microenvironment and focal therapy for prostate cancer	2
Editorial: Metastatic prostate cancer: a wealth of data to put into practice	2
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer	2
Molecular research in bladder cancer	2
Imaging in stone diagnosis and surgical planning	2
Editorial introductions	2
Techniques and outcomes of percutaneous tumour ablation for small renal masses	2
Association between male infertility and prostate cancer: a systematic review and meta-analysis: erratum	2
Climate change and urologic care: a challenge for patients and providers	2
Current developments in prehabilitation in urologic oncology	2
Should we redefine the Phoenix criteria for biochemical recurrence after primary radiotherapy?	2
Prevention and management of urinary tract infections after cystectomy	2
Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology	2
Metastasectomy in renal cell carcinoma: where are we now?	2
Extended pelvic lymph node dissection in muscle invasive bladder cancer	2
Urological impact of flozins (SGLT2 inhibitors): an EAU Endourology review of risks, side effects and clinical considerations	2
Trends in outpatient versus inpatient urologic surgery at a university academic medical center	2
Poly-ADP ribose polymerase inhibitor and androgen receptor signaling inhibitor for all comers for first-line treatment of metastatic castration-resistant prostate cancer: is gene sequencing out?	2
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023	2
Transurethral resection of bladder cancer with or without fluorescence	2
Editorial: genetics in urology	2
Organ-sparing treatment for T1 and T2 penile cancer: an updated literature review	2
Renal cell carcinoma with inferior vena cava thrombus: did we make progress in oncologic outcomes and complications?	2
Recent developments in perioperative combination therapy in muscle-invasive bladder cancer	2